This new SelectScience® eBook aims to provide you with useful resources, expert insight, and application-based case studies to help simplify your choice when it comes to developing efficient, reproducible CAR-T cell workflows.
An exciting area of immunotherapy focuses on the use of cytotoxic T lymphocytes (T cells) to target and eliminate cancer cells. However, tumor cells are able to evade T cell destruction by not expressing certain antigens. By creating recombinant T cell receptors (TCRs), known as chimeric antigen receptors (CARs), that target the antigens present on a patient’s specific tumor, CAR-Ts utilize the body’s own immune system to kill tumor cells.
In this exclusive eBook, we present key factors, important considerations and workflows to help guide you through CAR-T cell therapy discovery and development. Download the SelectScience CAR-T cell therapy workflow solutions eBook to find out more about: